LIFE RE CORP
10-Q, 1998-08-12
LIFE INSURANCE
Previous: GREEN TREE FINANCIAL CORP, 8-K, 1998-08-12
Next: GOLDEN EAGLE GROUP INC, 10-Q, 1998-08-12



<PAGE>   1
                                    FORM 10-Q

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

(MARK ONE)
/X/               QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                      OF THE SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1998

                                       OR

/ /             TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                         COMMISSION FILE NUMBER 1-11340

                               LIFE RE CORPORATION
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

           DELAWARE                                   01-0437851
(STATE OR OTHER JURISDICTION OF           (I.R.S. EMPLOYER IDENTIFICATION NO.)
 INCORPORATION OR ORGANIZATION)
                               969 HIGH RIDGE ROAD
                           STAMFORD, CONNECTICUT 06905
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)


                                 (203) 321-3000
              (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)

         INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS
REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE
REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO SUCH
FILING REQUIREMENTS FOR THE PAST 90 DAYS.  YES X  NO

         COMMON STOCK OUTSTANDING ($.001 PAR VALUE) AS OF AUGUST 10, 1998:
17,286,279 SHARES




<PAGE>   2
                                                                          Page 2



                                TABLE OF CONTENTS

Item                                                                        Page

                         PART I - FINANCIAL INFORMATION

 1       Financial Statements

         Independent Accountants' Review Report

         Condensed Consolidated Balance Sheets (Unaudited)
         June 30, 1998 and December 31, 1997

         Condensed Consolidated Statements
         of Income (Unaudited)
         Three and six months ended June 30, 1998 and 1997

         Condensed Consolidated Statements
         of Cash Flows (Unaudited)
         Six months ended June 30, 1998 and 1997

         Notes to Condensed Consolidated Financial
         Statements June 30, 1998 (Unaudited)


 2       Management's Discussion and Analysis of
         Financial Condition and Results of Operations


                           PART II- OTHER INFORMATION


 2       Changes in Securities

 4       Submission of Matters to a Vote of
         Security Holders

 5       Other Information

 6       Exhibits and Reports on Form 8-K

         Exhibit Index




<PAGE>   3
                                                                          Page 3
PART I - FINANCIAL INFORMATION

ITEM 1
                                  Independent Accountants' Review Report


The Board of Directors
Life Re Corporation

We have reviewed the accompanying condensed consolidated balance sheet of Life
Re Corporation and its subsidiaries as of June 30, 1998, and the related
condensed consolidated statements of income for the three-month and six month
periods ended June 30, 1998 and 1997, and the condensed consolidated statements
of cash flows for the six-month periods ended June 30, 1998 and 1997. These
condensed consolidated financial statements are the responsibility of the
Company's management.

We conducted our reviews in accordance with standards established by the
American Institute of Certified Public Accountants. A review of interim
financial information consists principally of applying analytical procedures to
financial data, and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit conducted in
accordance with generally accepted auditing standards, which will be performed
for the full year with the objective of expressing an opinion regarding the
financial statements taken as a whole. Accordingly, we do not express such an
opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to the accompanying condensed consolidated financial statements referred
to above for them to be in conformity with generally accepted accounting
principles.

We have previously audited, in accordance with generally accepted auditing
standards, the consolidated balance sheet of Life Re Corporation and
subsidiaries as of December 31, 1997 and the related consolidated statements of
income, shareholders' equity and cash flows for the year then ended (not
presented herein) and in our report dated February 12, 1998 (except for Notes 9
and 10, as to which the date is March 17, 1998), we expressed an unqualified
opinion on those consolidated financial statements. In our opinion, the
information set forth in the accompanying condensed consolidated balance sheet
as of December 31, 1997, is fairly stated, in all material respects, in relation
to the consolidated balance sheet from which it has been derived.


                                                    /s/
                                                    --------------------------
                                                         ERNST & YOUNG LLP
Stamford, Connecticut
July 26, 1998



<PAGE>   4
PART I, ITEM 1.
LIFE RE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)



<TABLE>
<CAPTION>
                                                                              JUNE 30,          DECEMBER 31,
                                                                                 1998               1997
                                                                             -----------        -----------
                                                                                     (In thousands,
                                                                                   except share data)
<S>                                                                          <C>                <C>
ASSETS

Fixed maturities - at fair value
     (amortized cost: $3,176,829 and $2,243,423, respectively)               $ 3,287,158        $ 2,335,795
Equity securities - at fair value
     (cost: $27,764 and $25,171, respectively)                                    29,145             26,775
Assets held by ceding company under reinsurance treaty - at fair value
     (amortized cost: $101,329 and $101,767, respectively)                       109,663            109,266
Mortgage loans and real estate                                                    38,680             12,007
Short-term investments                                                           191,971            166,801
Policy loans                                                                     183,729            133,986
                                                                             -----------        -----------
     Total investments                                                         3,840,346          2,784,630

Cash                                                                               5,863             16,797
Accrued investment income                                                         64,399             43,378
Policy revenues receivable                                                       170,133            158,560
Amounts receivable on reinsurance ceded                                          336,772            347,828
Deferred acquisition costs                                                       468,048            325,570
Other assets                                                                      24,099             23,479
                                                                             -----------        -----------
     Total assets                                                            $ 4,909,660        $ 3,700,242
                                                                             ===========        ===========

LIABILITIES

Policy benefits                                                              $ 3,583,517        $ 2,871,243
Acquisition costs payable                                                         57,663             54,247
Amounts due on reinsurance ceded                                                  59,394             55,085
Other liabilities                                                                215,632            120,877
Loans payable                                                                    125,000            125,000
                                                                             -----------        -----------
     Total liabilities                                                         4,041,206          3,226,452
                                                                             -----------        -----------

Corporation-obligated, mandatorily redeemable capital securities
     of subsidiary trusts                                                        236,620            100,000
                                                                             -----------        -----------

COMMON SHAREHOLDERS' EQUITY

Common stock (par value $.001 per share;
     authorized 40,000,000 shares; issued 19,502,185
     and 15,835,785 shares, respectively)                                             20                 16
Paid in capital                                                                  334,086            111,337
Net unrealized appreciation of securities                                         70,123             61,416
Retained earnings                                                                276,573            249,297
Treasury stock - at cost (2,215,906 and 2,205,223
     shares, respectively)                                                       (48,968)           (48,276)
                                                                             -----------        -----------
     Total common shareholders' equity                                           631,834            373,790
                                                                             -----------        -----------
     Total liabilities and shareholders' equity                              $ 4,909,660        $ 3,700,242
                                                                             ===========        ===========
</TABLE>




 The accompanying notes are an integral component of the condensed consolidated
financial statements.


<PAGE>   5
LIFE RE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)


<TABLE>
<CAPTION>
                                                     THREE MONTHS ENDED           SIX MONTHS ENDED
                                                          JUNE 30,                     JUNE 30,
                                                  -----------------------       ----------------------
                                                    1998           1997           1998          1997
                                                  --------       --------       --------       -------
                                                                        (In thousands,
                                                                    except per share data)
<S>                                               <C>            <C>            <C>            <C> 
REVENUES

Policy revenues                                   $161,093       $122,608       $302,412       $237,321 
Investment income                                   57,539         36,328        105,349         71,237
Realized investment gains                              122          1,052            715          1,789
  Total revenues                                  --------       --------       --------       -------
                                                   218,754        159,988        408,476       310,347
                                                  --------       --------       --------       -------

BENEFITS AND EXPENSES

Policy benefits                                    110,236         86,422        206,011       168,612
Acquisition costs                                   44,423         36,312         85,624        68,228
Interest credited to policyholder accounts          18,753          7,929         33,196        18,143
Interest expense                                     1,961          1,993          3,942         3,981
Distributions on capital securities                  4,229            606          6,728           606
Other operating expenses                            12,072          8,191         23,878        16,784
  Total benefits and expenses                     --------       --------       --------       -------
                                                   191,674        141,453        359,379       276,354
                                                  --------       --------       --------       -------

Income before federal income taxes                  27,080         18,535         49,097        33,993
Provision for federal income taxes                   9,478          6,488         17,184        11,898
                                                  --------       --------       --------       -------

NET INCOME                                        $ 17,602         12,047       $ 31,913       $22,095
                                                  ========       ========       ========       =======


Earnings per common share                         $   1.02       $   0.89       $   2.02       $  1.63
                                                  ========       ========       ========       =======


Earnings per common share assuming dilution       $   0.97       $   0.85       $   1.92       $  1.57
                                                  ========       ========       ========       =======


Dividends per common share                        $   0.15       $   0.13       $   0.30       $  0.26
                                                  ========       ========       ========       =======
</TABLE>


The accompanying notes are an integral component of the condensed consolidated
financial statements.


<PAGE>   6
LIFE RE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

<TABLE>
<CAPTION>
                                                                                SIX MONTHS ENDED
                                                                                     JUNE 30,
                                                                            --------------------------
                                                                              1998             1997
                                                                            ---------        ---------
                                                                                  (In thousands)
<S>                                                                         <C>              <C>      
OPERATING ACTIVITIES

Income before federal income taxes                                          $  49,097        $  33,993
Adjustments to reconcile income before federal income taxes to
     net cash provided by operating activities:
         Change in accrued investment income                                  (11,898)          (1,443)
         Change in policy revenues receivable, net                                495           (4,497)
         Change in policy benefits                                             29,093          (10,348)
         Change in reinsurance ceded balances                                  (8,392)          14,031
         Interest credited to policyholder accounts                            33,196           18,143
         Fees and charges deducted from policyholder accounts                 (32,020)         (18,178)
         Deferral of acquisition costs                                        (29,320)         (28,782)
         Amortization of acquisition costs, net of interest accretion           8,055            9,710
         Net realized gains on investments                                       (715)          (1,789)
         Depreciation and amortization                                          2,859              443
         Other                                                                (17,563)          10,945
                                                                            ---------        ---------
             Net cash provided by operations                                   22,887           22,228
         Federal income taxes recovered (paid)                                (22,725)           1,294
                                                                            ---------        ---------
            Net cash provided by operating activities                             162           23,522
                                                                            ---------        ---------

INVESTING ACTIVITIES

Purchases of fixed maturities                                                (984,240)        (223,166)
Sales of fixed maturities                                                     451,622          127,389
Maturities of fixed maturities                                                 68,541           28,295
Purchases of equity securities                                                 (2,040)
Sales or redemptions of equity securities                                       2,572
Change in short-term investments,  policy loans and other investments         214,141          (19,837)
Short-term borrowings                                                          89,758
Cash paid in connection with acquisitions and
     reinsurance transactions, net                                           (160,611)
Other, net                                                                     (1,290)          (1,218)
                                                                            ---------        ---------
            Net cash used by investing activities                            (321,547)         (88,537)
                                                                            ---------        ---------

FINANCING ACTIVITIES

Purchases of common stock for treasury                                           (692)            (956)
Proceeds from exercises of common stock options                                 3,732            1,982
Issuance of common stock, net of issuance costs                               219,120
Issuance of corporation-obligated, mandatorily redeemable
     capital securities of subsidiary trust                                   133,177           99,034
Dividends on common stock                                                      (4,637)          (3,528)
Deposits to policyholder accounts                                              41,499           25,180
Withdrawals from policyholder accounts                                        (81,748)         (53,962)
                                                                            ---------        ---------
           Net cash provided by financing activities                          310,451           67,750
                                                                            ---------        ---------
Increase (decrease) in cash                                                   (10,934)           2,735
Cash, beginning of period                                                      16,797            6,337
                                                                            ---------        ---------
Cash, end of period                                                         $   5,863        $   9,072
                                                                            =========        =========
</TABLE>

The accompanying notes are an integral component of the condensed consolidated
financial statements.

<PAGE>   7
                                                                          Page 5



1.       BASIS OF PRESENTATION

         The accompanying unaudited condensed consolidated financial statements
of Life Re Corporation and Subsidiaries (the "Company") have been prepared in
accordance with generally accepted accounting principles for interim financial
information and with the instructions to Form 10-Q and Article 10 of Regulation
S-X. Accordingly, they do not include all of the information and footnotes
required by generally accepted accounting principles for complete financial
statements. In the opinion of management, all adjustments, consisting solely of
normal recurring accruals considered necessary for a fair presentation of
financial results, have been included. Operating results for the six month
period ended June 30, 1998 are not necessarily indicative of the results that
may be expected for the year ending December 31, 1998. For further information,
refer to the consolidated financial statements and notes thereto included in the
Company's Annual Report on Form 10-K for the year ended December 31, 1997.

         Certain reclassifications have been made to the prior year financial
statements to conform to the current year presentation.

         All amounts are reported in thousands except per share data or unless
otherwise specified.

     Earnings per common share is computed using the weighted average number of
common shares outstanding during the periods presented. Earnings per share
assuming dilution reflects the dilution that could occur if options to purchase
common stock granted under the Company's stock option plans were exercised. The
following table presents the effect of dilutive common stock options.

<TABLE>
<CAPTION>
                                                          Three Months Ended         Six Months Ended
                                                               June 30,                   June 30,
                                                          ---------------------------------------------
                                                           1998         1997         1998         1997
                                                          ------       ------       ------       ------
<S>                                                       <C>          <C>          <C>          <C>   
Weighted average common shares outstanding                17,282       13,569       15,767       13,560
Net effect of stock options assumed to be exercised          905          522          862          535
                                                          ------       ------       ------       ------

Total common shares assuming dilution                     18,187       14,091       16,629       14,095
                                                          ======       ======       ======       ======
</TABLE>

         As of January 1, 1998, the Company adopted Statement of Financial
Accounting Standards No. 130, "Reporting Comprehensive Income" ("SFAS 130"),
which establishes new rules for the reporting and display of comprehensive
income and its components, consisting of net income and other comprehensive
income. The accumulated balance of other comprehensive income is required to be
reported separately in common shareholders' equity. The Company's only component
of 


<PAGE>   8
                                                                          Page 6



other comprehensive income is net unrealized gains or losses on available for
sale securities, as defined, which is reported separately in common
shareholders' equity. Therefore, the adoption of SFAS 130 has no impact on
common shareholders' equity. Comprehensive income, which will be reported in the
Statement of Changes in Common Shareholders' Equity on an annual basis, is as
follows:

<TABLE>
<CAPTION>
                                                    Three Months Ended            Six Months Ended
                                                          June 30,                     June 30,
                                                  -----------------------------------------------------
                                                    1998           1997           1998           1997
                                                  --------       --------       --------       --------
<S>                                               <C>            <C>            <C>            <C>     
Net income                                        $ 17,602       $ 12,047       $ 31,913       $ 22,095
Net unrealized gains (losses) on securities         13,573         24,153          8,707         (2,325)
                                                  --------       --------       --------       --------

  Total comprehensive income                      $ 31,175       $ 36,200       $ 40,620       $ 19,770
                                                  ========       ========       ========       ========
</TABLE>

2.       CAPITAL SECURITIES AND SHAREHOLDERS' EQUITY

         On March 17, 1998, the Company completed two separate public offerings
(together, the "Offerings") in which it sold 3,500,000 shares of common stock
and 2,070,000 6.0% Adjustable Conversion-rate Equity Security Units (the
"Units") issued through Life Re Capital Trust II, a subsidiary of the Company.
The Units consist of stock purchase contracts and Quarterly Income Preferred
Securities. Net proceeds from the Offerings were $352,297 of which $207,000 was
contributed to the insurance subsidiaries.

3.       ACQUISITIONS AND REINSURANCE TRANSACTION

         Effective February 28, 1998, the Company acquired, for a purchase price
of $61,596, 100% of the common stock of Mission Life Insurance Company
("Mission"). The fair value of assets acquired and liabilities assumed were
approximately $261,000 and $200,000, respectively.

         Effective April 1, 1998, the Company acquired, for a purchase price of
$46,600, 100% of the common stock of Lincoln Liberty Life Insurance Company and
First Delaware Life Insurance Company from First Lincoln Holdings, Inc. The
combined fair value of the assets acquired and the liabilities assumed were
approximately $243,000 and $196,000, respectively.

         Also effective April 1, 1998, the Company recaptured certain business
it had retroceded to ERC Life Insurance Company. The portion recaptured amounted
to 20% of the total block of business coinsured from Allianz Life Insurance
Company effective December 31, 1997.
<PAGE>   9
                                                                          Page 7


         Effective June 30, 1998, the Company acquired, for a purchase price of
$29,338, 100% of the common stock of North American Financial Services, Inc.,
the parent of Atlas Life Insurance Company. The fair value of the assets
acquired and liabilities assumed were approximately $229,000 and $200,000,
respectively.

         Also effective June 30, 1998, the Company acquired, for a purchase
price of $70,834, 100% of the common stock of Capitol Bankers Life Insurance
Company, an indirect subsidiary of The Manufacturers Life Insurance Company. The
fair value of the assets acquired and liabilities assumed were approximately
$196,000 and $125,000, respectively.

         On July 24, 1998, the Company entered into an agreement to acquire 100%
of the common stock of Eagan Holding Company, the parent of First Capital Life
Insurance Company of Louisiana ("First Capital Life"), for a purchase price of
approximately $24,000. The acquisition, which is subject to regulatory
approvals, is expected to close in the third quarter. First Capital Life had
statutory assets of approximately $80,000 at March 31, 1998.

4.       SUBSEQUENT EVENT

         On July 27, 1998, the Company and Swiss Reinsurance Company ("Swiss
Re") entered into a definitive agreement (the "Merger Agreement") pursuant to
which Swiss Re will acquire the Company in a merger transaction (the "Merger")
for $95.00 per share, provided that if the closing is delayed by Swiss Re after
all conditions are otherwise satisfied, stockholders shall also be entitled to
receive an additional payment per share equal to $.0208 per day from, but not
including, the date on which the closing would have occurred absent the exercise
by Swiss Re of its right to delay the closing, to, and including, the closing
date. The aggregate cash purchase price of the Merger transaction is
approximately $1.8 billion.

         The Merger is subject to certain customary closing conditions,
including, without limitation, the approval of the Merger Agreement by the
requisite vote of the stockholders of the Company in accordance with applicable
law, the representations and warranties of each of Swiss Re, Swiss Re's
subsidiary formed to consummate the acquisition ("Sub") and the Company being
true and correct in all material respects on and as of the effective time of the
merger (the "Effective Time"), each of Swiss Re, Sub and the Company having
performed in all material respects its obligations to be performed prior to the
Effective Time under the Merger Agreement, and the receipt of all material
consents, authorizations, orders, approvals and filings of any governmental
entity required in connection with the Merger (including all insurance
regulatory approvals) shall have been obtained or made.

         The Merger Agreement will be subject to termination at any time prior
to the Effective Time by (i) the mutual consent of Swiss Re and the Company,
(ii) either Swiss Re, Sub or the Company if the Company's stockholders fail to
<PAGE>   10
                                                                          Page 8


approve and adopt the Merger Agreement at the Company's special meeting of
stockholders, if any court or governmental entity has taken action to
permanently restrain, enjoin or otherwise prohibit the Merger and such action
has become final and non-appealable, or if the Effective Time shall not have
occurred before January 31, 1999, or (iii) if the Company receives a superior
proposal from a bona fide third party under certain circumstances. If the Merger
Agreement is terminated by the Company because it has received a superior
proposal, then the Company shall promptly pay Swiss Re a fee of $60 million.
Additionally, if following termination of the Merger Agreement, the Company
enters into an acquisition agreement within 12 months of such termination with a
person that previously made a takeover proposal to the Company, or announced an
intention to make a takeover proposal, then the Company shall promptly pay Swiss
Re a fee of $60 million.


<PAGE>   11
                                                                          Page 9


ITEM 2.
LIFE RE CORPORATION AND SUBSIDIARIES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS

         With the exception of historical information, the matters contained in
the following analysis are "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section 21E of the
Securities Exchange Act of 1934, as amended. Such statements may include, but
are not limited to, projections of earnings, revenues, income or loss, capital
expenditures, plans for future operations and financing needs or plans, as well
as assumptions relating to the foregoing. The words "expect", "project",
"estimate", "predict", "anticipate", "believes" and similar expressions are also
intended to identify forward-looking statements. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot be predicted
or quantified. Future events and actual results, performance and achievements
could differ materially from those set forth in, contemplated by or underlying
the forward-looking statements. Such factors include, but are not limited to,
(i) uncertainties relating to general economic and business conditions which may
impact the reinsurance marketplace; (ii) changes in laws and government
regulations applicable to the Company; (iii) the ability of the Company to
implement its operating strategies successfully; (iv) the ability of the Company
to execute Administrative ReinsuranceSM transactions and the amount, timing and
returns thereof and therefrom: (v) material fluctuations in interest rate
levels; (vi) material changes in mortality and morbidity experience; (vii)
material changes in persistency; (viii) material changes in the level of
operating expenses; (ix) success or failure of certain of the Company's clients
in premium writing; (x) significant changes in competitive factors affecting the
Company; (xi) occurrences affecting the Company's ability to obtain funds from
operations, debt or equity to finance growth in its businesses; and (xii) other
risks and uncertainties. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect, actual outcomes
may vary materially from those indicated.

RESULTS OF OPERATIONS

         During 1997 and the first six months of 1998, the Company completed
several transactions through which it acquired blocks of insurance in force
(collectively, the "Transactions"). Transactions completed in 1997 (the "1997
Transactions") increased total assets by approximately $930 million. The
transactions completed in 1998 (the "1998 Transactions") increased total assets
by approximately $720 million.
<PAGE>   12
                                                                         Page 10



         On June 6, 1997, the Company completed a private placement under Rule
144A of the Securities Act of 1933 of $100,000 of 8.72% capital securities of
Life Re Capital Trust I, a subsidiary of the Company (the "1997 Offering"). On
March 17, 1998, the Company completed two separate public offerings in which it
sold 3,500,000 shares of common stock (the "Common Stock Issuance") and
2,070,000 6.0% Adjustable Conversion-rate Equity Security Units (the "Units")
issued through Life Re Capital Trust II, a subsidiary of the Company (the "1998
Offering"). The Units consist of a stock purchase contract and Quarterly Income
Preferred Securities.

SIX MONTHS ENDED JUNE 30, 1998 COMPARED TO SIX MONTHS ENDED JUNE 30, 1997

         Net income was $31.9 million for the six months ended June 30, 1998
compared to $22.1 million for the same period last year. The increase is due to
the contribution to administrative reinsurance from the Transactions and higher
premium volumes and lower relative mortality in traditional reinsurance.

         Policy revenues by major source for the six months ended June 30, 1998
and 1997 are as follows:

<TABLE>
<CAPTION>
(in millions)                                1998          1997
                                            -------       -------
<S>                                         <C>           <C>    
Traditional reinsurance                     $ 194.7       $ 153.4
Administrative reinsurance                     70.2          23.1
Group accident and health and special
  risk reinsurance                             37.5          60.8
                                            -------       -------
                                            $ 302.4       $ 237.3
                                            =======       =======
</TABLE>

         Policy revenues increased by $65.1 million, or 27%, to $302.4 million
from $237.3 million in the same period last year. Traditional life reinsurance
policy revenues increased by $41.3 million, or 27%, to $194.7 million due to an
increase in first year premiums of $7.0 million and higher renewal premiums
resulting from higher in force amounts. The $47.1 million increase in
administrative reinsurance policy revenues is attributable to the Transactions.
Group accident and health and special risk policy revenues decreased by $23.3
million, or 38%, to $37.5 million. This decrease is due to the Company's
withdrawal from the group accident and health and special risk marketplace
during 1997 and an agreement, effective January 1, 1997, to retrocede 50% of
1997 group accident and health and special risk reinsurance risks.

         Investment income increased by 48% to $105.3 million as a result of
assets received in conjunction with the Transactions, and the proceeds received
from the Common Stock Issuance and 1998 Offering, partially offset by a decline
in the weighted average portfolio yield rate as of June 30, 1998 compared to
June 30, 
<PAGE>   13
                                                                         Page 11


1997.

         Policy benefits increased by $37.4 million period to period due to
higher volumes of business in force; as a percentage of policy revenues, policy
benefits improved to 68% in 1998 from 71% in 1997. The decrease in the ratio
largely was due to shift in the mix of business within traditional reinsurance
from excess to first dollar quota share reinsurance. Under first dollar quota
share reinsurance, typically a higher portion of the reinsurance premium funds
acquisition costs and a lesser portion funds mortality costs. In addition, in
1998 there is higher proportion of administrative reinsurance business, which
generally possesses lower benefit ratios due to a significant portion of policy
benefit costs on interest sensitive products being classified as interest
credited.

         Policy acquisition costs as a percentage of policy revenues were 28%
for the 1998 period compared to 29% for the comparable prior year period. The
decrease largely is attributable to the decline in group accident and health and
special risk business, which generally possesses a higher acquisition cost ratio
and the growth in the administrative reinsurance business, which generally
possesses lower acquisition cost ratios. The decrease was offset partially by an
increase in the acquisition cost ratio within traditional reinsurance as a
result of the aforementioned mix in business from excess to first dollar quota
share.

         Interest credited to policyholder accounts increased to $33.2 million
in 1998 from $18.1 million in 1997 corresponding to the growth in interest
sensitive business resulting from the Transactions.

         Interest expense on loans payable was level at $4.0 million for 1998
and 1997, as rates and amounts outstanding generally were unchanged.

         Distributions on capital securities of $6.7 million were incurred from
the issuance of the 1997 and 1998 Offerings.

         Other operating expenses increased by $7.1 million to $23.9 million due
to administrative fees for third party administrators incurred within
administrative reinsurance due to the Transactions and higher compensation
costs.

         Federal income taxes were provided at the federal statutory rate of 35%
for 1998 and 1997.


SECOND QUARTER OF 1998 COMPARED TO SECOND QUARTER OF 1997

         Net income was $17.6 million for the three months ended June 30, 1998
compared to $12.1 million for the same period last year. The increase is due to
higher premium volumes and lower relative mortality in traditional reinsurance
and the contribution to administration reinsurance from the Transactions.
<PAGE>   14
                                                                         Page 13

         Policy revenues by major source for the periods ended June 30, 1998 and
1997 are as follows:

<TABLE>
<CAPTION>
(in millions)                                1998          1997
                                            -------       -------
<S>                                         <C>           <C>
Traditional reinsurance                     $ 103.5       $  81.5
Administrative reinsurance                     38.1          14.0
Group accident and health and special
  risk reinsurance                             19.5          27.1
                                            -------       -------
                                            $ 161.1       $ 122.6
                                            =======       =======
</TABLE>

         Policy revenues increased by $38.5 million, or 31%, to $161.1 million
in 1998 from $122.6 million in last year's second quarter. Traditional life
reinsurance policy revenues increased by $22.0 million, or 27%, to $103.5
million due to an increase in first year premiums of $2.1 million and higher
renewal premiums resulting from higher in force amounts. The $24.1 million
increase in administrative reinsurance policy revenues primarily is attributable
to the Transactions. Group accident and health and special risk policy revenues
decreased by $7.6 million, or 28%, to $19.5 million. This decrease is due to the
Company's withdrawal from the group accident and health and special risk
marketplace during 1997 and an agreement, effective January 1, 1997, to
retrocede 50% of 1997 group accident and health and special risk reinsurance
risks.

         Investment income increased by 58% to $57.5 million as a result of
assets received in conjunction with the Transactions, and the proceeds received
from the Common Stock Issuance and 1998 Offering, partially offset by a decline
in the weighted average portfolio yield rate as of June 30, 1998 compared to
June 30, 1997.

         Policy benefits increased by $23.8 million period to period due to
higher volumes of business in force, but, as a percentage of policy revenues,
improved to 68% in 1998 from 71% in 1997. The decrease largely was due to shift
in the mix of business within traditional reinsurance from excess to first
dollar quota share reinsurance. Under first dollar quota share reinsurance,
typically a higher portion of the reinsurance premium funds acquisition costs
and a lesser portion funds mortality costs. In addition, there is higher
proportion of administrative reinsurance business, which generally possesses
lower benefit ratios due to a significant portion of policy benefit costs on
interest sensitive products being classified as interest credited.

         Policy acquisition costs as a percentage of policy revenues were 28%
for the 1998 period compared to 30% for the comparable prior year quarter. The
decrease largely is attributable to the decline in group accident and health and
special risk business, which generally possesses a higher acquisition cost ratio
and the growth in the administrative reinsurance business, which generally
possesses lower 
<PAGE>   15
                                                                         Page 14


acquisition cost ratios. The decrease was offset partially by an increase in the
acquisition cost ratio within traditional reinsurance as a result of the
aforementioned mix in business from excess to first dollar quota share.

         Interest credited to policyholder accounts increased to $18.8 million
in 1998 from $7.9 million in 1997 corresponding to the growth in interest
sensitive business resulting from the Transactions.

         Interest expense on loans payable was level at $2.0 million for 1998
and 1997, as rates and amounts outstanding generally were unchanged.

         Distributions on capital securities of $4.2 million were incurred from
the issuance of the 1997 and 1998 Offerings.

         Other operating expenses increased by $3.9 million to $12.1 million due
to administrative fees for third party administrators incurred within
administrative reinsurance due to the Transactions and higher compensation
costs.

         Federal income taxes were provided at the federal statutory rate of 35%
for 1998 and 1997.


FINANCIAL CONDITION AND LIQUIDITY

INVESTMENTS

         Invested assets totaled $3,840.3 million at June 30, 1998 compared to
$2,784.6 million at December 31, 1997 largely due to assets acquired from the
Transactions and proceeds from the Common Stock Issuance and 1998 Offering.

         The Company's fixed maturity portfolio (including the fixed maturity
securities which are included in assets held by ceding company under reinsurance
treaty) constituted 88% of invested assets at June 30, 1998, of which $99.8
million, or 3% of invested assets, consisted of below investment grade
securities. At June 30, 1998, the weighted average quality rating of the fixed
maturities portfolio was A2/A and no fixed maturities were in default.

LIQUIDITY

         Sources of liquidity are available to the Company in the form of cash
and short-term investments and, if necessary, the sale of invested assets. The
Company may enter into reverse repurchase agreements to fund short-term cash
needs and can also borrow an additional $35.0 million under its revolving credit
agreement. In addition to debt servicing and dividend and capital securities
distribution obligations, the Company's financial obligations consist of policy
benefit
<PAGE>   16
                                                                         Page 15


and acquisition costs, taxes and general operating expenses. Management believes
that these obligations will be adequately provided for by policy revenues and
investment income for the next twelve months.

         In order to provide additional liquidity and capital needed to support
its core businesses, the Company raised capital in the quarter ended March 31,
1998 (see Note 2 of "Notes to Condensed Consolidated Financial Statements")
through the Common Stock Issuance and 1998 Offering.

         The ability of the Company to make principal and interest payments
under its credit agreement as well as to continue to pay common stock dividends
ultimately is dependent on the statutory earnings and surplus of the insurance
subsidiaries. The transfer of funds from the subsidiaries to the Company is
subject to applicable insurance laws and regulations.


<PAGE>   17
                                                                         Page 16




PART II - OTHER INFORMATION


ITEM 4

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         (a)      The meeting was held on May 14, 1998 and it was the Annual
                  Meeting of Stockholders.

         (b)      The meeting involved the election of directors and the
                  following directors were each elected to serve a three (3)
                  year term:

                  Rodney A. Hawes, Jr.
                  Chris C. Stroup
                  T. Bowring Woodbury, II

                  The name of each other director whose term of office as a
                  director continued after the meeting is as follows:

                  Jacques E. Dubois                  Carolyn K. McCandless
                  Douglas M. Schair                  K. Fred Skousen

         (c)      Four (4) matters were voted upon at the meeting: (i) the
                  election of directors; (ii) the amendment to the 1992 Life Re
                  Corporation Stock Option Plan authorizing an increase from
                  3,000,000 to 4,500,000 in the number of shares of Life Re
                  Corporation common stock available for issuance; (iii) the
                  amendment to the Life Re Corporation Restated Certificate of
                  Incorporation to increase the authorized number of shares of
                  common stock from 40,000,000 to 80,000,000; and (iv) the
                  ratification of the appointment of independent auditors for
                  the year 1998.

                  (i)      ELECTION OF DIRECTORS:

                           Nominee                   Votes For    Votes Withheld

                           Rodney A. Hawes, Jr.      15,309,647       242,132

                           Chris C. Stroup           15,308,827       242,952

                           T. Bowring Woodbury, II   15,317,687       234,092



<PAGE>   18
                                                                         Page 17




         (ii) AMENDMENT TO THE 1992 LIFE RE CORPORATION STOCK OPTION PLAN
AUTHORIZING AN INCREASE FROM 3,000,000 TO 4,500,000 IN THE NUMBER OF SHARES OF
LIFE RE CORPORATION COMMON STOCK AVAILABLE FOR ISSUANCE

              Votes For        Votes Against              Abstentions

              9,466,203        4,991,627                  54,109

         (iii) AMENDMENT TO THE LIFE RE CORPORATION RESTATED CERTIFICATE OF
INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK FROM
40,000,000 TO 80,000,000

              Votes For        Votes Against              Abstentions

              14,547,118       953,352                    51,309

         (iv) RATIFICATION OF AUDITORS:

              Votes For        Votes Against              Abstentions

              15,539,142       4,158                      8,479


ITEM 5

OTHER INFORMATION

         On July 27, 1998, Life Re Corporation and Swiss Reinsurance Company
("Swiss Re") entered into an agreement whereby Swiss Re will acquire Life Re
Corporation for $95.00 per common share. The agreement is subject to shareholder
and regulatory approvals and certain other conditions and is more fully
described in Note 4 "Notes to Consolidated Financial Statements."

         In order to limit the ability of management proxies to exercise their
discretionary voting authority with respect to any stockholder proposal for the
regular annual meeting of the stockholders of Life Re Corporation in the year
1999, where the stockholder has not sought inclusion of the proposal in the Life
Re Corporation proxy statement, Life Re Corporation must receive notice of the
proposal no later than February 24, 1999. Such notices should be sent to the
Life Re Corporation Corporate Secretary at 969 High Ridge Road, Stamford, CT
06905.


<PAGE>   19
                                                                         Page 18




ITEM 6

EXHIBITS AND REPORTS ON FORM 8-K

         (a)      Exhibits


                  3.01     Restated Certificate of Incorporation of Life Re
                           Corporation (the "Company"), dated November 13, 1997,
                           incorporated by reference to Exhibit 3.01 of the
                           Company's Form 10-Q for the quarterly period ended
                           September 30, 1997, as filed with the Securities and
                           Exchange Commission ("SEC") on November 13, 1997.

                  3.02     Amendment to the Restated Certificate of
                           Incorporation of the Company, dated June 19, 1998.

                  3.03     Bylaws of the Company, dated August 5, 1992,
                           incorporated by reference to Exhibit 3.02 of the
                           Company's Form 10-Q for the quarterly period ended
                           September 30, 1997, as filed with the SEC on November
                           13, 1997.

                  4.01     Specimen Common Stock Certificate of the Company,
                           incorporated by reference to Exhibit 4.1 of the
                           Company's Registration Statement on Form S-1 (File
                           No. 33-50556).

                  4.02     Certificate of Trust of Life Re Capital Trust II
                           ("Trust II"), incorporated by reference to Exhibit
                           4.3 of the Company's Registration Statement on Form
                           S-3 (File No. 333-46213).

                  4.03     Declaration of Trust of Trust II, incorporated by
                           reference to Exhibit 4.4 of the Company's
                           Registration Statement on Form S-3 (File No.
                           333-46213).

                  4.04     Form of Amended and Restated Declaration of Trust of
                           Trust II, incorporated by reference to Exhibit 4.5 of
                           the Company's Registration Statement on Form S-3
                           (File No. 333-46213).

                  4.05     Form of Quarterly Income Preferred Security ("QUIPS")
                           of Trust II, incorporated by reference to Exhibit 4.6
                           of the Company's Registration Statement on Form S-3
                           (File No. 333-46213).

                  4.06     Form of Junior Subordinated Debenture, incorporated
                           by reference to Exhibit 4.8 of the Company's
                           Registration Statement on Form S-3 (File No.
                           333-46213).

                  4.07     Form of Indenture between the Company and The Bank of
                           New York, as Trustee, 
<PAGE>   20
                                                                         Page 19


                           pursuant to which the Junior Subordinated Debentures
                           are to be issued, incorporated by reference to
                           Exhibit 4.7 of the Company's Registration Statement
                           on Form S-3 (File No. 333-46213).

                  4.08     Form of Guarantee Agreement with respect to the
                           QUIPS, incorporated by reference to Exhibit 4.9 of
                           the Company's Registration Statement on Form S-3
                           (File No. 333-46213).

                  4.09     Form of Master Unit Agreement, incorporated by
                           reference to Exhibit 4.11 of the Company's
                           Registration Statement on Form S-3 (File No.
                           333-46213).

                  4.10     Form of Adjustable Conversion-rate Equity Security
                           Units, incorporated by reference to Exhibit 4.12 of
                           the Company's Registration Statement on Form S-3
                           (File No. 333-46213).

                  4.11     Form of Pledge Agreement, incorporated by reference
                           to Exhibit 4.13 of the Company's Registration
                           Statement on Form S-3 (File No. 333-46213).

                  4.12     Form of Call Option Agreement, incorporated by
                           reference to Exhibit 4.14 of the Company's
                           Registration Statement on Form S-3 (File No.
                           333-46213).

                  4.13     Company's Agreement to File Indenture, incorporated
                           by reference to Exhibit 4.02 of the Company's Form
                           10-Q for the quarterly period ended June 30, 1997, as
                           filed with the SEC on August 13, 1997.

                  10.01    Resignation Agreement, effective as of March 31,
                           1998, between the Company and Samuel V. Filoromo.

                  10.02    Amendment Number Three to the 1992 Life Re
                           Corporation Stock Option Plan.

                  10.03    April 15, 1998 Amendment to the Amended and Restated
                           Advisory Agreement, dated November 16, 1988, between
                           Life Reassurance and Conseco Capital Management, Inc.

                  15.01    Acknowledgment Letter of Ernst & Young LLP.

                  27.01    Financial Data Schedule.


         (b)      A Current Report on Form 8-K was filed on July 27, 1998 with
                  respect to the proposed transaction between Life Re
                  Corporation and Swiss Reinsurance Company. No Current Reports
                  on Form 8-K were filed during the three months ended June 30,
                  1998.



<PAGE>   21
                                                                         Page 20






         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                                              Life Re Corporation




Dated:  August 12, 1998                       By: /s/ Chris C. Stroup
                                                  ---------------------------
                                                  Chris C. Stroup,
                                                  Executive Vice President
                                                  and Chief Financial Officer






<PAGE>   22
                                                                         Page 21


                                  EXHIBIT INDEX



         3.02     Amendment to the Restated Certificate of Incorporation of the
                  Company, dated June 19, 1998.

         10.01    Resignation Agreement, effective as of March 31, 1998, between
                  the Company and Samuel V. Filoromo.

         10.02    Amendment Number Three to the 1992 Life Re Corporation Stock
                  Option Plan.

         10.03    April 15, 1998 Amendment to the Amended and Restated Advisory
                  Agreement, dated November 16, 1988, between Life Reassurance
                  and Conseco Capital Management, Inc.

         15.01    Acknowledgment Letter of Ernst & Young LLP.

         27.01    Financial Data Schedule.






<PAGE>   1
                                                                         Page 22


                                                                    EXHIBIT 3.02


                           CERTIFICATE OF AMENDMENT TO
                    RESTATED CERTIFICATE OF INCORPORATION OF
                               LIFE RE CORPORATION


         Life Re Corporation (the "Corporation"), a corporation organized and
existing under the Delaware General Corporation Law, hereby certifies that:

         ARTICLE 1. The name of the Corporation is Life Re Corporation.

         ARTICLE 2. The first sentence of ARTICLE FOUR of the Restated
Certificate of Incorporation of the Corporation is hereby amended to read as
follows: The total number of shares which the Corporation shall have the
authority to issue is eighty five million (85,000,000) shares, of which eighty
million (80,000,000) shares, $0.001 par value, shall be Common Stock, and five
million (5,000,000) shares, $0.01 par value, shall be Preferred Stock.

         ARTICLE 3. This amendment was duly adopted by a vote of the directors
and of the stockholders in accordance with the provisions of Section 242 of the
Delaware General Corporation Law.

         IN WITNESS WHEREOF, Life Re Corporation has caused this Certificate to
be executed in its name and on its behalf by Jacques E. Dubois, its President
and Chief Operating Officer, and attested by W. Weldon Wilson, its Secretary, on
this 19th day of June, 1998.
                                              LIFE RE CORPORATION
   
                                              By: /S/ Jacques E. Dubois
                                                  ------------------------------
                                                    Jacques E. Dubois, President
                                                    and Chief Operating Officer
ATTEST:

/S/ Weldon Wilson
- ----------------------------
W. Weldon Wilson, Secretary








<PAGE>   1
                                                                         Page 23


                                                                   EXHIBIT 10.01

         This RESIGNATION AGREEMENT (this "Agreement") is made effective as of
the 31st day of March, 1998 (the "Effective Date") by and between Life Re
Corporation, a Delaware corporation having its principal executive offices at
969 High Ridge Road, Stamford, Connecticut (hereinafter referred to,
collectively with its subsidiaries, as the "Company") and Samuel V. Filoromo
(referred to as the "Executive").

                               W I T N E S S E T H

         WHEREAS, the Executive and the Company entered into an Employment
Agreement, effective as of June 1, 1996 (the "Employment Agreement"); and

         WHEREAS, the Executive wishes to terminate his employment with the
Company, subject to the terms and conditions set forth herein.

         NOW, THEREFORE, the Company and the Executive hereby agree as follows:

1. DEFINITIONS. Unless defined in this Agreement, terms that are capitalized
will have the meanings set forth in the Employment Agreement.

2. TERMINATION OF EMPLOYMENT.

         (A) The Executive hereby voluntarily resigns from and terminates his
employment with the Company, effective as of March 31, 1998 (the "Termination
Date").

         (B) Effective as of the Termination Date, the Executive hereby resigns
from all offices and directorships of the Company and its subsidiaries he holds
as of such date.

         (C) The Executive and the Company agree that SECTION 9(A) of the
Employment Agreement shall be amended in its entirety to read as follows:

                           "(a) If the Company terminates the Executive's
                  employment with the Company during the term of this Agreement
                  for Disability or any reason other than for Cause or
                  subsequent to a Change in Control, or if the Executive
                  terminates his employment with the Company during the term of
                  this Agreement for Good Reason pursuant to paragraph 8(c)
                  above, the Company will pay or provide the Executive, as
                  severance pay or liquidated damages or both:

                                    (i) Base Salary through the Date of
                           Termination at the rate in effect at the time Notice
                           of Termination is given, together with any other
                           amounts payable to the Executive under paragraph 6
                           above for periods prior to the Date of Termination;

                                    (ii) a lump sum payment, on the eighth
                           business day after the 
<PAGE>   2
                                                                         Page 24


                           Date of Termination, equal to the sum of (A) the Base
                           Salary at the rate in effect as of the Date of
                           Termination from the Date of Termination through
                           February 28, 1999, and (B) $76,200;

                                    (iii) employee benefits and service credit
                           for employee benefits and employee benefit accruals
                           which the Executive would have received under
                           paragraph 6(f) above if the Executive's employment
                           had continued under this Agreement until the later of
                           (i) one year from the Date of Termination or (ii) the
                           date for the termination of this Agreement provided
                           in paragraph 3 above;

                                    (iv) all options held by the Executive
                           become immediately vested and the Executive has the
                           right to exercise the options at any time from the
                           Date of Termination until the expiration of such
                           options as provided in the individual option
                           agreements; and

                                    (v) any amounts payable under paragraph 20
                           below."

         (D) The Company agrees that in consideration for the resignation of the
Executive, the Company will pay or provide to the Executive the items provided
by SECTION 9(a) of the Employment Agreement, as modified by this Agreement, as
if the Executive's employment was terminated by the Company other than for
Cause. The Executive and the Company agree that for purposes of determining
amounts payable the "Date of Termination" shall be March 31, 1998. The Executive
and the Company agree to waive the requirement for a Notice of Termination as
provided in the Employment Agreement.

         (E) The Executive and the Company agree that no other provision of the
Employment Agreement is modified by this Agreement, except as specifically set
forth in this Agreement. All other protections, indemnifications and rights
provided in the Employment Agreement for the Executive, other than the rights
related to continued employment, continue in full force and effect.

         (F) The Executive understands and agrees that the payments and benefits
enumerated in this Agreement and the Employment Agreement (as modified by this
Agreement and including payments provided therein for employee benefit plans)
are all that he is or will be entitled to receive from the Company in connection
with his termination of employment, and to the extent that he, or anyone
claiming through him, is or may by entitled to additional payments or benefits
with respect to such termination pursuant to the Employment Agreement, any stock
option agreement, any Company severance pay plan, or any other agreement, plan
or arrangement with or of the Company, such agreement, plan or arrangement is
hereby modified to limit the payment or benefits thereunder to those
contemplated by this Agreement.

         (G) The Executive and the Company agree that the Indemnification
Agreement 
<PAGE>   3
                                                                         Page 25


between the Executive and the Company, dated August 4, 1992 (the
"Indemnification Agreement"), regarding tax indemnification for the Executive's
purchase of restricted stock, shall remain in force until April 16, 2002,
subject to extensions of the statute of limitations for the Executive's 1998
federal income tax return.

3.       RELEASE.

         (A) In connection with this Agreement, and in consideration for the
promises of the Company, the Executive agrees to provide a release of all claims
the Executive or anyone claiming through him has or may have against the
Company, in a form acceptable to the parties.

         (B) In connection with this Agreement, and in consideration for the
promises of the Executive, the Company, on its behalf and on behalf of its
successors, hereby releases and forever discharges the Executive from any and
all actions, or causes of action, suits, debts, claims, complaints, contracts,
controversies, agreements, promises, damages and demands of any nature
whatsoever, at law or in equity, that the Company ever had, now has, or may have
as of the date of this Agreement, other than claims with respect to acts by the
Executive of willful misconduct which acts (i) are unknown to the Company as of
the date of this Agreement and (ii) have had or are likely to result in
substantial economic damage to the Company.

         (C) The Company promises never to file a lawsuit or administrative
complaint asserting any claims that are released in SECTION 3(B) of this
Agreement.

4.       NON-DISPARAGEMENT.

         (A) The Executive agrees not to disparage the Company, its employees,
directors, stockholders, or officers, so as to affect adversely their business
or reputation.

         (B) The Company agrees that the senior executive officers of Life Re
Corporation will not disparage the Executive so as to affect adversely the
Executive's business or reputation.

5.       MISCELLANEOUS.

         (A) The Executive is responsible for any tax liability associated with
payments provided under this Agreement. The Company has the right to withhold
taxes from such payments to the extent required by law.

         (B) This Agreement, the Employment Agreement, the Indemnification
Agreement, and various stock options agreements constitute the entire agreement
between the Executive and the Company. The Company has made no promises to the
Executive other than those in this Agreement. This Agreement may not be amended
or terminated except 
<PAGE>   4
                                                                         Page 26


by a writing signed by the parties hereto.

         (C) This Agreement may not be assigned by either party without the
prior written consent of the other party, except that no consent is necessary
for the Company to assign this Agreement to a corporation succeeding to
substantially all the assets or business of the Company whether by merger,
consolidation, acquisition or otherwise. This Agreement shall be binding upon
the Executive, his heirs and permitted assigns and the Company, its successors
and permitted assigns.

         (D) This Agreement shall be governed by the laws of the State of
Connecticut.


         IN WITNESS WHEREOF, the parties hereto have executed this Agreement on
the date set forth below.

                                      THE COMPANY:                              
                                      
                                      LIFE RE CORPORATION
                                      
                                      
                                      By: /s/ Rodney A. Hawes, Jr.
                                          --------------------------------------
                                            Rodney A. Hawes, Jr.
                                            Chairman and Chief Executive Officer
                                      
                                      Dated: March 30, 1998
                                      
                                      
                                      THE EXECUTIVE:
                                      
                                      
                                      /s/ Samuel V. Filoromo
                                      ------------------------------------------
                                      Samuel V. Filoromo
                                      
                                      Dated: March 30, 1998




<PAGE>   5
                                                                         Page 27




                               RELEASE AND WAIVER


         This Release and Waiver (the "Release") is made as of the 31st day of
March, 1998 by and between Samuel V. Filoromo (the "Executive") and Life Re
Corporation (collectively with its subsidiaries, the "Company").

         WHEREAS, the parties set forth their mutual understanding concerning
the termination of the Executive's employment with the Company in the
Resignation Agreement (the "Agreement"), which is hereby incorporated herein;
and

         WHEREAS, the certain promises in the Agreement constitute consideration
for execution of this Release by the Executive; and

         WHEREAS, in the Agreement the Executive agreed to execute this Release.

         NOW THEREFORE, the parties agree to be bound by the following terms:

         1. CONSIDERATION. As consideration for the Executive signing this
Release, the Company will make the payments and provide the benefits to the
Executive that are described in the Agreement. The parties agree that the
payments and benefits enumerated in the Agreement that constitute consideration
for the Executive signing this Release are in excess of any payments or benefits
to which the Executive may otherwise be entitled.

         2. RELEASE. The Executive, on behalf of himself and his heirs, legal
representatives, estates and successors in interest, hereby releases and forever
discharges the Company from any and all actions, or causes of action, suits,
debts, claims, complaints, contracts, controversies, agreements, promises,
damages and demands of any nature whatsoever, at law or in equity, that the
Executive ever had, now has, or may have as of the date of this Agreement,
including without limitation any claims alleging (i) wrongful discharge, (ii)
discrimination based on race, sex, color, religious creed, marital status,
national origin, ancestry, present or past history of mental disability or
physical disorder, sexual orientation, or age (including rights and claims under
the Age Discrimination in Employment Act), or (iii) breach of any express or
implied contract, or violation of any local, state, or federal law, regulation
or ordinance having any bearing whatsoever on the terms and conditions of the
Executive's employment with the Company.

         3. NO FUTURE LAWSUITS, COMPLAINTS OR CLAIMS. The Executive promises
never to file a lawsuit or administrative complaint asserting any claims that
are released in SECTION 2 of this Release.

         4. NONRELEASE OF FUTURE CLAIMS. This Release does not waive or release
any rights or claims that the Executive may have under the Age Discrimination in
Employment Act which arise after the effective date of this Release.



<PAGE>   6
                                                                         Page 28




         5. PERIOD FOR REVIEW AND CONSIDERATION OF RELEASE. The Executive
confirms that he has twenty-one (21) days to review and consider this release
before signing it. The Executive understands that he may use as much or as
little of this period as he wishes prior to signing.

         6. ENCOURAGEMENT TO CONSULT WITH AN ATTORNEY. The Executive is
encouraged, at his own expense, to consult with an attorney before signing this
Release.

         7. EXECUTIVE'S RIGHT TO REVOKE RELEASE. The Executive may revoke this
release within seven (7) business days of the date of the Executive's signature.
revocation can be made by delivering a written notice of the revocation to the
Chief Executive Officer of the Company. For this revocation to be effective,
written notice must be received no later than the close of business on the
seventh (7th) business day after the Executive signs this Release. If the
Executive revokes this Release, it shall not be effective or enforceable and the
Executive will not receive the payment and/or benefits described in the
Agreement.

         8. SEVERABILITY. The parties agree that the provisions of this Release
are severable and divisible. In the event any portion of this Release is
determined to be illegal or unenforceable, the remaining provisions of this
release shall remain in full force and effect.

         9. REMEDIES. In addition to other rights the Company may have, should
the Executive breach any of the terms of this release, including specifically,
but not limited to, the representations and promises contained in SECTION 2, the
Company will have the right to cease any and all payments under the Agreement.
Such action will have no effect on the Release contained herein.

         10. EFFECTIVE DATE OF RELEASE. The effective date of this release shall
be seven (7) business days from the date on which this Release is signed and
dated by the Executive.

         11. OTHER BENEFITS. Anything herein to the contrary notwithstanding,
this Release shall not affect the Executive's rights under (i) the Resignation
Agreement, including the right to enforce that agreement, (ii) the Employment
Agreement, as amended, dated as of June 1, 1996 between the Company and the
Executive, or (iii) any vested rights under the Company's pension or employee
benefit plans.






<PAGE>   7
                                                                         Page 29




THE EXECUTIVE ACKNOWLEDGES THAT HE HAS READ THIS RELEASE,
UNDERSTANDS IT AND IS VOLUNTARILY ENTERING INTO IT.


         IN WITNESS WHEREOF, the parties hereto have executed this Release as of
the date set forth below.

                                      THE COMPANY:                              
                                      
                                      LIFE RE CORPORATION
                                      
                                      
                                      By: /s/ Rodney A. Hawes, Jr.
                                          --------------------------------------
                                            Rodney A. Hawes, Jr.
                                            Chairman and Chief Executive Officer
                                      
                                      Dated: March 30, 1998
                                      
                                      
                                      THE EXECUTIVE:
                                      
                                      
                                      /s/ Samuel V. Filoromo
                                      ------------------------------------------
                                      Samuel V. Filoromo
                                      
                                      Dated: March 30, 1998










<PAGE>   1
                                                                         Page 30




                                                                   EXHIBIT 10.02




                             Amendment Number Three

                         to the 1992 Life Re Corporation

                                Stock Option Plan



<PAGE>   2
                                                                         Page 31




                             Amendment Number Three
                         to the 1992 Life Re Corporation
                                Stock Option Plan


         This Amendment Number Three (this "Amendment") to the 1992 Life Re
Corporation Stock Option Plan is entered into by the Board of Directors (the
"Board") of Life Re Corporation (the "Company") to be effective on the Effective
Date (as hereinafter defined).

                                   WITNESSETH

         WHEREAS, the Company maintains a stock option plan, the 1992 Life Re
Corporation Stock Option Plan, as previously amended (the "Plan"), for the
benefit of its "key personnel"; and

         WHEREAS, the Board of Directors is empowered to amend the
Plan pursuant to Section 3.1 thereof; and

         WHEREAS, the Board of Directors wishes to amend the Plan to increase
the number of shares of Common Stock available for issuance thereunder.

         NOW, THEREFORE, the Board of Directors has determined that the Plan
shall be amended, effective as of the date set forth below, as follows:

         1. Defined Terms.  Terms not defined herein will have the meanings
assigned to such terms under the Plan.

         2. Increase of Shares. Section 1.5(b) of the Plan is hereby amended and
restated to read as follows:

         "(b) Subject to Section 3.5 (relating to adjustments upon changes in
capitalization), as of any date the total number of shares of Common Stock with
respect to which options may be granted under the Plan shall be equal to the
excess (if any) of (i) 4,500,000 minus (ii) the sum of (A) the number of shares
subject to outstanding options granted under the Plan, and (B) the number of
shares previously transferred pursuant to the exercise of options granted under
the Plan. In accordance with (and without limitation upon) the preceding
sentence, shares of Common Stock covered by options granted under the Plan which
are cancelled, expire or terminate for any reason whatsoever shall again become
available for awards under the Plan."


<PAGE>   3
                                                                         Page 32





         3. Effective Date. This Amendment shall be effective as of the date it
is approved by the stockholders of the Company.

         4. Governing Law. This Amendment shall be governed by the same law as
applies to the interpretation of the Plan.

         IN WITNESS WHEREOF, this Amendment is executed on this 12th day of
February 1998 to be effective on the Effective Date.



                                LIFE RE CORPORATION


                                By:          /s/ Rodney A. Hawes, Jr.
                                             -----------------------------------
                                Name:        Rodney A. Hawes, Jr.
                                Title:       Chairman and Chief
                                             Executive Officer


<PAGE>   1
                                                                         Page 33




                                                                   EXHIBIT 10.03


                        CONSECO CAPITAL MANAGEMENT, INC.
                            11825 N. Pennsylvania Street
                                           P.O. Box 1925
                                   Carmel, Indiana 46032
                                            317.817.2804


                                                                   March 2, 1998
Mr. Weldon W. Wilson
Executive Vice President
General Counsel & Secretary
Life Reassurance Corporation of America
969 High Ridge Rd.
Stamford, CT 06905

RE:    LIFE REASSURANCE CORPORATION
       LIFERE CORPORATION
       REASSURE AMERICA LIFE INSURANCE COMPANY
       TEXASRE LIFE INSURANCE COMPANY
         INVESTMENT ADVISORY AGREEMENT

Dear Mr. Wilson:

We are writing to inform you of some revisions to the language of the scope of
liability clause in our standard form of investment advisory agreement. In order
to better track the language generally prescribed by the Securities and Exchange
Commission for these types of clauses, we have, among other changes, removed the
word "gross" before "negligence", removed the words "willful misfeasance" and
substituted "malfeasance", and removed the words "in bad faith" from the same
clause in paragraph (a). We also have made some stylistic changes.

We would like to incorporate the revised clause in the Investment Advisory
Agreement between us. The revised clause, which would replace paragraphs (a),
(b) and (c) of Section 8 of that Agreement, reads as follows:

         8.       Scope of Liability

         (a) Subject to paragraph (c) below, neither the Adviser nor any
shareholder, officer, director or employees thereof shall be liable to the
Company, or to the Board of Directors of the Company or to any shareholder of
the Company, for errors of judgment or other errors or for any losses that may
be sustained in connection with the purchase, holding, redemption or sale of any
security on behalf of the Company except to the extent such liability or losses
result from negligence or malfeasance or violation of applicable law.

         (b) Subject to paragraph (c) below, the Adviser and its stockholders,
officers, directors and employees may (but are not required to) consult with the
officers or directors of the Company, the Company's legal counsel and/or the
Company's independent accountants and shall not be liable for any action taken
or omission suffered in good faith, reasonable reliance upon and in accordance
with the written opinion or written 
<PAGE>   2
                                                                         Page 34


advice of any such officer, counsel or accountants.

         (c) The federal securities laws impose liabilities under certain
circumstances on persons who act in good faith and therefore nothing in
paragraphs (a) and (b) above shall in any way constitute a waiver or limitation
of any rights which the Company may have under any federal securities laws.

Please evidence your agreement to the replacement of those paragraphs of that
Agreement with the above paragraphs by signing the enclosed copy of this letter
and returning it to us in the enclosed envelope. Please also attach this letter
to your copy of the current Investment Advisory Agreement between us. If you
have any questions, please do not hesitate to call your Portfolio Manager or
Bill Latimer, our Senior Counsel, at 317/817-6863.

Sincerely,


/S/ MAXWELL E. BUBLITZ

Maxwell E. Bublitz
President

AGREED TO:

LIFE REASSURANCE CORPORATION
LIFERE CORPORATION
REASSURE AMERICA LIFE INSURANCE COMPANY
TEXASRE LIFE INSURANCE

By:  /S/ BRUCE I. WEISER                             APRIL 15,     1998
   ---------------------                             ------------------
                  (Signature)                        Dated


         BRUCE I. WEISER
          (Printed Name)



<PAGE>   1
                                                                         Page 35




                                                                   EXHIBIT 15.01



Acknowledgment Letter



The Board of Directors
Life Re Corporation



We are aware of the incorporation by reference in the Registration Statement
(Form S-8 Number 33-54138) pertaining to The Life Re Corporation Stock
Investment Plan, the Registration Statement (Form S-8 No. 33-80251) pertaining
to the Life Re Corporation Stock Option Plan, the Registration Statement (Form
S-8 No. 33-80737) pertaining to the Life Re Corporation 1993 Non-Employee
Directors Stock Option Plan and in the Registration Statement (Form S-3 No.
333-35031) pertaining to the registration of shares of common stock in
connection with certain employees' restricted stock grant of our report dated
July 26, 1998 relating to the unaudited condensed consolidated interim financial
statements of Life Re Corporation that are included in its Form 10-Q for the
quarter ended June 30, 1998.



                                                       /s/
                                                       ------------------------
                                                          ERNST & YOUNG LLP



Stamford, Connecticut
July 26, 1998

<TABLE> <S> <C>

<ARTICLE> 7                           
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                    6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<DEBT-HELD-FOR-SALE>                         3,287,158
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                      29,145
<MORTGAGE>                                      38,680
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                               3,840,346
<CASH>                                           5,863
<RECOVER-REINSURE>                             336,772
<DEFERRED-ACQUISITION>                         468,048
<TOTAL-ASSETS>                               4,909,660
<POLICY-LOSSES>                              3,583,517
<UNEARNED-PREMIUMS>                                  0
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                125,000
                                0
                                          0
<COMMON>                                            20
<OTHER-SE>                                     631,814
<TOTAL-LIABILITY-AND-EQUITY>                 4,909,660
                                     302,412
<INVESTMENT-INCOME>                            105,349
<INVESTMENT-GAINS>                                 715
<OTHER-INCOME>                                       0
<BENEFITS>                                     206,011
<UNDERWRITING-AMORTIZATION>                     85,624
<UNDERWRITING-OTHER>                                 0
<INCOME-PRETAX>                                 49,097
<INCOME-TAX>                                    17,184
<INCOME-CONTINUING>                             31,913
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    31,913
<EPS-PRIMARY>                                     2.02
<EPS-DILUTED>                                     1.92
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission